These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28574441)

  • 1. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.
    Pfeifer A; Wojtas B; Oczko-Wojciechowska M; Kukulska A; Czarniecka A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Rusinek D; Tyszkiewicz T; Kowal M; Jarzab M; Hauptmann S; Lange D; Paschke R; Jarzab B
    BMC Med Genomics; 2013 Oct; 6():38. PubMed ID: 24099521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.
    Jikuzono T; Ishikawa T; Hirokawa M; Sugitani I; Ishibashi O
    BMC Res Notes; 2020 May; 13(1):241. PubMed ID: 32404135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction.
    Taniguchi K; Takano T; Miyauchi A; Koizumi K; Ito Y; Takamura Y; Ishitobi M; Miyoshi Y; Taguchi T; Tamaki Y; Kato K; Noguchi S
    Oncology; 2005; 69(5):428-35. PubMed ID: 16319515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
    Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
    Cerutti JM; Delcelo R; Amadei MJ; Nakabashi C; Maciel RM; Peterson B; Shoemaker J; Riggins GJ
    J Clin Invest; 2004 Apr; 113(8):1234-42. PubMed ID: 15085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms.
    Affinito O; Salerno P; D'Alessio A; Cuomo M; Florio E; Carlomagno F; Proietti A; Giannini R; Basolo F; Chiariotti L; Cocozza S; Santoro M
    Endocr Relat Cancer; 2019 Apr; 26(4):451-462. PubMed ID: 30753136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.